HER2-targeted CAR T-cell Therapy Safe, With Promising Antitumor Activity in Patients With Advanced Sarcoma
ATLANTA – A combination of chemotherapy and chimeric antigen receptor (CAR) T cells designed to target the protein HER2...
ATLANTA – A combination of chemotherapy and chimeric antigen receptor (CAR) T cells designed to target the protein HER2...
ATLANTA – A combination of the anti-CTLA-4 immunotherapeutic ipilimumab (Yervoy) and the anti-PD-1 immunotherapeutic nivolumab (Opdivo) showed clinical benefit...
ATLANTA – Adding the investigational MET inhibitor savolitinib to the EGFR inhibitor osimertinib (Tagrisso) yielded clinical responses in patients...
ATLANTA – A chimeric antigen receptor (CAR) T-cell therapy that targets the protein mesothelin showed no evidence of major...
PHILADELPHIA – The American Association for Cancer Research (AACR) will recognize Cornelis J.M. Melief, MD, PhD, with the seventh...
Five new members elected to the Board of Directors PHILADELPHIA – The members of the American Association for Cancer...
PHILADELPHIA – Poor oral health was associated with increased risk of pancreatic cancer in African-American women, according to results...
Awardees to be recognized at the AACR Annual Meeting 2019 PHILADELPHIA – The American Association for Cancer Research (AACR)...
PHILADELPHIA – The American Association for Cancer Research (AACR) will present Distinguished Public Service Awards to three individuals whose...
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced its newly elected class of Fellows of the...